Comment
Author: Admin | 2025-04-28
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders Service Appreciation Initiative to increase access to safe and affordable weight loss treatment Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform committed to breaking down barriers to safe and affordable healthcare, today announced access to the most common compounded GLP-1 subscriptions for as low as $99 a month for eligible U.S. military, veterans, teachers, nurses and first responders. Hims & Hers provides increased access to safe and affordable weight loss treatment at up to a 50% discount to help the heroes in their communities with their health and wellness. (Graphic: Business Wire) Providing access to safe, affordable weight loss solutions is more critical than ever yet many Americans do not have consistent access to these life-changing treatments. Hims & Hers is introducing the Service Appreciation Initiative to give eligible U.S. military, veterans, teachers, nurses and first responders the ability to benefit from compounded semaglutide GLP-1s at significantly lower costs. GLP-1 medications can support healthy weight loss along with a reduced calorie diet and increased exercise by helping manage blood sugar levels, curb cravings and suppress appetite, so people eat less without feeling deprived. Hims & Hers offers a comprehensive weight loss solution personalized for individuals which may include compounded GLP-1 injections or oral weight loss medication kits as deemed appropriate by the healthcare provider. Hims & Hers weight loss customers have seen tremendous success on weight loss treatments. Based upon self-reported data from approximately 12,000 customers subscribed to a comprehensive Hims & Hers weight loss offering, customers report having lost, on average, 10.2 pounds while on compounded GLP-1 injections and 6.3 pounds while on non-GLP-1 compounded oral medication kits, along with a reduced calorie diet and exercise, between their initial weight at consultation and their first check-in approximately 4 weeks later. “The current state of access to weight loss drugs isn’t serving everyone who needs them,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “Safe and affordable healthcare solutions for every individual should be the status quo. This initiative has the potential to make a lasting impact in our communities by providing more reliable, consistent access to these life-changing medications for the millions of Americans who want a better, more affordable way to take care of
Add Comment